A medical device designed to make it easy for women to avoid unwanted pregnancies has been found to cause serious blood clot injuries. Cases have been consolidated in multidistrict litigation (MDL).
Merck representatives face more than a thousand women with their lawyers across the mediation table, but it seems that a trial may be unavoidable. The issue at hand is the serious side effects of using the contraceptive device NuvaRing manufactured by the pharmaceutical company. Because of the large number of lawsuits coming in, the cases have been consolidated in Missouri’s Eastern District in an MDL which was supposed to start on October 21, 2013. The start date has been pushed back to January 27, 2014, apparently to give more time for mediation.
In the meantime, more and more women are coming in to file new cases against Merck. Currently, there are 1,358 cases waiting for representation in court, and more may be coming in as soon as those affected by NuvaRing realize that they may be eligible for compensation.
NuvaRing was first introduced into the market in 2000, and because it was so easy to use, it was widely successful as an alternative to other birth control methods. Millions of women have been using it before health experts figured out that it induced dangerous levels of blood clotting which can cause stroke, pulmonary embolism or deep vein thrombosis.